InvestorsHub Logo
Followers 93
Posts 17832
Boards Moderated 0
Alias Born 11/26/2014

Re: None

Wednesday, 11/23/2016 9:41:18 AM

Wednesday, November 23, 2016 9:41:18 AM

Post# of 32393
GNID CEO and Management Really placed the BAR High on the value of their COMPANY.
.0036

On September 26, 2016, Crownbridge elected to convert $2,473 of the principal amount of note issued on January 12, 2016. The Company issued to Crownbridge 687,000 shares of Company stock

Having businesses, understand the "back against the wall", but no EXCUSE for using this FINANCING for these salaries. This is far from that scenario...

Lorraine Maria Yarde $200,000.00+ CEO
Mark Basile $175,000.00+ General Counsel
Glenn McGinnis $150.000,00 VP Product Development
William V. Koch $150,000.00 Chief Sales and Marketing
Faruk Okcetin $125,000.00 President GENE-RX
J. Richard Iler $125,000.00 CFO
Susan K. Kutzner $$$ Shares + Treasurer & Director

GNID shareholders GET SOLD OUT for subway fare. BJMO
NY, MI, NC, CA, OH



Invest in yourself. Control your own Destiny.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.